100% Quality Guarantee
PhD-Level Technical Support
Key Features

APC Anti-Human CD273/PD-L2 Antibody [24F.10C12] (AGEL1862)

SKU AGEL1862
Product Type Antibody
Antibody Type Monoclonal Antibody
Reactivity Human
Applications FC
€125 - €488

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

APC Anti-Human CD273/PD-L2 Antibody [24F.10C12]

The Human CD273 (PD-L2) Monoclonal Antibody (APC Conjugated) is a cutting-edge tool for researchers studying immune regulation and immune checkpoint molecules. This monoclonal antibody, designated as 24F.10C12, is specifically designed for the detection and analysis of CD273 (PD-L2) protein in human samples. By conjugating it with APC, this antibody enables highly sensitive and specific flow cytometry analysis.CD273, also known as programmed death ligand 2 (PD-L2), is a crucial immune checkpoint molecule that plays a pivotal role in immune response modulation and maintaining peripheral tolerance. Its interaction with the programmed death receptor 1 (PD-1) on T cells is implicated in regulating T cell activation and immune responses.

The aberrant expression or dysregulation of CD273 has been linked to various diseases, including cancer, autoimmune disorders, and infectious diseases.By using the Human CD273 (PD-L2) Monoclonal Antibody (APC Conjugated) in your research, you can delve into the intricate mechanisms of immune regulation, gain insights into immune escape strategies in cancer, and explore new avenues for immunotherapy development. This antibody is a valuable tool for elucidating the role of CD273 in immune modulation and its potential as a therapeutic target in immuno-oncology and autoimmune diseases research.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose